Kenvue Inc

Company Profile

• Business description

  Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

• Contact

  199 Grandview Road
  SkillmanNJ08558
  USA

  T: +1 908 874-1200

  https://www.kenvue.com

• Sector

  Consumer Defensive

  Stock type

  Defensive

• Industry

  Household & Personal Products

  Fiscal Year End

  31 December 2025

  Employees

  22,000